R E Parchment - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

R E Parchment

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Cancer Chemotherapy and Pharmacology|January 1, 1996

Myelotoxic effects of the bifunctional alkylating agent bizelesin on human, canine and murine myeloid progenitor cellsD A Volpe, J E Tomaszewski, R E Parchment, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001

The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathwaysZ Ding, R E Parchment, P M LoRusso, et al.

Toxicological Sciences : an Official Journal of the Society of Toxicology|January 3, 2001

In vitro human tissue models in risk assessment: report of a consensus-building workshopJ T MacGregor, J M Collins, Y Sugiyama, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Cancer Chemotherapy and Pharmacology|January 1, 1996

Myelotoxic effects of the bifunctional alkylating agent bizelesin on human, canine and murine myeloid progenitor cellsD A Volpe, J E Tomaszewski, R E Parchment, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001

The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathwaysZ Ding, R E Parchment, P M LoRusso, et al.

Toxicological Sciences : an Official Journal of the Society of Toxicology|January 3, 2001

In vitro human tissue models in risk assessment: report of a consensus-building workshopJ T MacGregor, J M Collins, Y Sugiyama, et al.

Pageof 4